[Antilipidemic activity of ethyl-chloro-phenoxy-isobutyrate or clofibrate].
D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002087:Butyrates / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002784:Cholesterol / Q000097:blood; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D007674:Kidney Diseases / Q000188:drug therapy*; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood; D008107:Liver Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy*
D000924:Anticholesteremic Agents; D002087:Butyrates; D008055:Lipids; D008074:Lipoproteins; D002784:Cholesterol
Attività antilipidemica dell'etil-cloro-fenossi-isobutirrato o clofibrate.